ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

CERT Certara Inc

17.60
-0.01 (-0.06%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Certara Inc CERT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.01 -0.06% 17.60 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
17.93 17.45 17.94 17.60 17.61
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/4/202407:00GLOBECertara Launches Cloud Platform to Further Unify its..
09/4/202415:15GLOBECertara to Report First Quarter 2024 Financial Results on..
06/3/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202418:26EDGAR2Form 144 - Report of proposed sale of securities
29/2/202415:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202415:21EDGAR2Form 8-K - Current report
29/2/202415:10GLOBECertara Reports Fourth Quarter 2023 Financial Results
21/2/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202411:25EDGAR2Form 144 - Report of proposed sale of securities
14/2/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202416:14EDGAR2Form 144 - Report of proposed sale of securities
01/2/202415:30GLOBECertara to Report Fourth Quarter and Full Year 2023..
27/12/202317:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202311:22EDGAR2Form 144 - Report of proposed sale of securities
13/12/202315:30GLOBECertara Acquires Applied BioMath Expanding Its Biosimulation..
21/11/202315:30GLOBECertara introduces Simcyp™ Biopharmaceutics software to..
08/11/202315:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:16EDGAR2Form 8-K - Current report
08/11/202315:10GLOBECertara Reports Third Quarter 2023 Financial Results
11/10/202315:15GLOBECertara to Report Third Quarter 2023 Financial Results on..
06/10/202316:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202307:15GLOBECertara Announces 300th Regulatory Submission Milestone..
29/8/202315:15GLOBECertara to Participate in Upcoming Investor Conferences
29/8/202307:15GLOBECertara Simcyp™ Group Awarded Two New Grants from US FDA
09/8/202315:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:15GLOBECertara Reports Second Quarter 2023 Financial Results
09/8/202315:11EDGAR2Form 8-K - Current report
03/8/202320:00BWCertara collaborates with Korea Institute of Toxicology to..
02/8/202315:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202315:30GLOBECertara to Report Second Quarter 2023 Financial Results on..
03/7/202316:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/6/202315:15GLOBECertara to Participate in the Jefferies Global Healthcare..
08/5/202315:15GLOBECertara Reports First Quarter 2023 Financial Results

Su Consulta Reciente

Delayed Upgrade Clock